Trends in teleconsultations for uveitis during the COVID-19 lockdown.
COVID-19 pandemic
India
lockdown
teleconsultation
telemedicine
teleophthalmology
uveitis
video consultation
Journal
Indian journal of ophthalmology
ISSN: 1998-3689
Titre abrégé: Indian J Ophthalmol
Pays: India
ID NLM: 0405376
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
5
3
2022
Statut:
ppublish
Résumé
To study the use of teleophthalmology as a tool to manage patients with uveitis and to describe the experience of teleconsultation for uveitis at a tertiary eye care hospital in India during the two waves of the COVID-19 pandemic. A prospective observational case series of uveitis patients seeking teleconsultations during the first (March 25-May 2020) and second lockdown (April 27 to June 21, 2021) in a tertiary eye care center were analyzed. There were 79 teleconsultations in the first and 89 teleconsultations in the second lockdown. A majority of the patients presented in the age group of 41-60 years in both the lockdowns. There were both new or primary consultations and follow-up patients (6% vs. 94%) in the first lockdown, and similarly in the second lockdown (8% new vs. 92% follow-up). The majority of patients resided in Bengaluru city (78% in the first and 76% in the second lockdown). After evaluation through video consultation, only 15% required a hospital referral in the first lockdown, whereas in the second lockdown, 21.3% were referred to the hospital. During the second lockdown, 20% presented with COVID-19 infection-related ailments. Based on our preliminary experience using a customized smartphone-based application for teleconsultation, we found it to be an alternative option to provide continuation of ophthalmic care to uveitis patients. Given the current COVID-19 situation, it can help avoid physical visits of uveitis patients to the hospital.
Identifiants
pubmed: 35225562
pii: IndianJOphthalmol_2022_70_3_1007_338174
doi: 10.4103/ijo.IJO_1759_21
pmc: PMC9114533
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1007-1012Déclaration de conflit d'intérêts
None
Références
Indian J Ophthalmol. 2020 Jul;68(7):1371-1379
pubmed: 32587167
JAMA Ophthalmol. 2020 Oct 01;138(10):1053-1060
pubmed: 32852513
J Med Virol. 2020 Jun;92(6):589-594
pubmed: 32100876
Indian J Ophthalmol. 2020 May;68(5):725-730
pubmed: 32317434
J Neuroophthalmol. 2020 Sep;40(3):292-304
pubmed: 32604249
Indian J Ophthalmol. 2020 Jul;68(7):1387-1391
pubmed: 32587172
Ocul Immunol Inflamm. 2020 Jul 3;28(5):709-713
pubmed: 32721206
Indian J Ophthalmol. 2020 Jul;68(7):1381-1384
pubmed: 32587169
Indian J Ophthalmol. 2020 Jul;68(7):1328-1338
pubmed: 32587158
Eye (Lond). 2020 Jul;34(7):1163-1164
pubmed: 32350447
Issues Med Ethics. 2002 Jul-Sep;10(3):66-70
pubmed: 16335489
Telemed J E Health. 2020 Jun;26(6):821-826
pubmed: 31502943
Graefes Arch Clin Exp Ophthalmol. 2020 Nov;258(11):2341-2352
pubmed: 32813110
BMJ Health Care Inform. 2020 Aug;27(3):
pubmed: 32796085
Indian J Ophthalmol. 2020 Jul;68(7):1316-1327
pubmed: 32587157
JAMA Ophthalmol. 2020 May 01;138(5):575-578
pubmed: 32232433
JAMA. 2020 May 12;323(18):1769-1770
pubmed: 32208485
Curr Opin Ophthalmol. 2020 Sep;31(5):366-373
pubmed: 32694270
Indian J Ophthalmol. 2020 Jun;68(6):962-973
pubmed: 32461407
Indian J Ophthalmol. 2021 Mar;69(3):714-718
pubmed: 33595507